American Well Corporation (NYSE:AMWL) Q4 2023 Earnings Conference Call February 14, 2024 5:00 PM ET
Company Participants
Sue Dooley - Head of Investor Relations
Ido Schoenberg - Chairman & Chief Executive Officer
Bob Shepardson - Chief Financial Officer
Conference Call Participants
Craig Hettenbach - Morgan Stanley
Jack Wallace - Guggenheim Securities
Charles Rhyee - TD Cowen
Eduardo Ron - Truist Securities
Eric Percher - Nephron Research
Jessica Tassan - Piper Sandler
Stan Berenshteyn - Wells Fargo Securities
Matt Shea - Needham & Company
Glen Santangelo - Jefferies
Operator
Good afternoon. My name is Brianna, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amwell Q4 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
I would now like to hand the call over to Sue Dooley, Head of Investor Relations with Amwell. You may begin.
Sue Dooley
Hello, everyone. Welcome to Amwell's conference call to discuss our fourth fiscal quarter and year end of 2023.
This is Sue Dooley of Amwell Investor Relations. And joining me today are Amwell's Chairman and CEO, Dr. Ido Schoenberg, and Bob Shepardson, our CFO.
Earlier today, we distributed a press release detailing our announcement. Our earnings release is posted on our website at investors.amwell.com and is also available through normal news sources.
This conference call is being webcast live on the IR page of our website where a replay will be archived.
Before we begin our prepared remarks, I'd like to take this opportunity to remind you that during the course of the call, we will make forward-looking statements regarding projected operating results and anticipated market opportunities. This forward-looking information is subject to the risks and uncertainties described in our filings with the SEC, and actual results or events may differ materially. Except as required by law, we undertake no obligation to update or revise these forward-looking statements.
On this call, we'll refer to both GAAP and non-GAAP financial measures. A reconciliation of GAAP to non-GAAP financial measures is provided in our posted earnings release.
With that, I'd like to turn the call over to Ido.
Ido Schoenberg
Thank you, Sue, and hello, everyone.
Q4 marked the close of the strategic year of Amwell. We advanced the breadth and maturity of our offering and migrated a big part of our installed base to our new platform, Converge. We have had an excellent reception to our solution, sizable market wins, powerful client validation and we documented compelling proof points. Also, we improved focus and efficiency in our company and are committed to continue optimizing our organization to streamline and propel growth.